( OTC-BB:NSPR )

News from InspireMD A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

11 Nov, 2013, 16:01 ET InspireMD Reports Financial Results for Quarter Ended September 30, 2013

 InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced financial results...


29 Oct, 2013, 16:23 ET InspireMD's MGuard Stent Shows Lower Mortality Rate in STEMI Patients at Twelve Months Compared to Control Group

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, today announced new 12-month results...


24 Oct, 2013, 09:15 ET InspireMD Secures Financing to Accelerate Advancements in Product Development and Adopts a One Year Stockholder Rights Plan

 InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced that it has secured $10...


24 Oct, 2013, 09:08 ET InspireMD Files At-the-Market Offering and Shelf Registration Statement

 InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, announced today that it has filed a $75...


23 Oct, 2013, 14:43 ET InspireMD to Ring Opening Bell at New York Stock Exchange on Thursday, October 24th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, announced today that it will ring the...


17 Sep, 2013, 16:05 ET InspireMD Reports Fourth Quarter and Fiscal Year 2013 Results

 InspireMD Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced financial results for...


06 Feb, 2012, 07:30 ET InspireMD Announces Positive Clinical Data From Trial of MGuard™

 InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and...


23 Jan, 2012, 08:00 ET InspireMD Provides Corporate Update, Plans for 2012

InspireMD, Inc. (OTC BB: NSPR) (the "Company" or "InspireMD"), a medical device company focusing on the development and...


17 Nov, 2011, 07:00 ET InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), a medical device company focusing on the development and commercialization of its...


15 Nov, 2011, 08:00 ET InspireMD Reports Record Third Quarter 2011 Operating and Financial Results and Strategic Update

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), a medical device company focusing on the development and commercialization of its...


24 Aug, 2011, 09:03 ET InspireMD to Present at the Rodman & Renshaw Annual Global Investment Conference

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, announced today that...


11 Aug, 2011, 08:00 ET InspireMD Elects Two New Board Members

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, today announced the...


26 Jul, 2011, 08:00 ET InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, announced today that...


13 Jul, 2011, 08:00 ET Sol J. Barer, Ph.D. Joins InspireMD Board of Directors

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, announced today that...


27 Jun, 2011, 09:17 ET InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, today announced it...


17 May, 2011, 08:00 ET InspireMD Announces Year-to-Date 2011 Progress

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, today announced that...


16 May, 2011, 08:00 ET InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week

InspireMD, Inc. (OTCBB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, will partake in the...


12 May, 2011, 12:45 ET InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, is happy to announce...


05 May, 2011, 13:00 ET InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"

InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, announced today that...


02 Mar, 2011, 09:49 ET InspireMD Boosts MGuard Production Capacity

InspireMD, developer of the MGuard™ net protective stent system, has expanded its MGuard production facilities to meet the steady increase...


17 Dec, 2010, 07:00 ET InspireMD Celebrates Successful ICI 2010 Meeting; Long-Term Data Validates MGuard as Potentially Important Tool in Modern Acute MI Therapy

InspireMD, developer of the novel MGuard(TM), a combination of a coronary stent merged with an embolic protection specifically designed for Acute...


23 Sep, 2010, 06:59 ET Inspire MD Will Sponsor a Satellite Symposium at TCT 2010 Where new and Unprecedented Long Term Results of MGuard Multicenter Experience in Stemi Patients Will be Presented for the First Time

- Further Exciting MGuard Clinical Findings Will be Revealed at this Year's TCT in Various Sessions Throughout the Meeting Concluding With a...


23 Sep, 2010, 06:59 ET InspireMD is Proud to Introduce MGuard Prime(R), InspireMD's new Cobalt Chromium MicroNet(R) Protective Stent System

InspireMD, developers of the novel MGuard(TM) coronary MicroNet stent system, will introduce MGuard Prime at its booth #2052 at the TCT Conference...


09 Sep, 2010, 03:59 ET Mesh-Based Protection is now Recommended for use in the new Guidelines of the Task Force of Myocardial Revascularization of the European Society of Cardiology (ESC)

InspireMD Ltd., a medical device company engaged in the development and commercialization of the mesh based MGuard(TM) stent systems, is proud to...


11 Aug, 2010, 07:00 ET InspireMD Announce That MGuard™ Is Now Available With a New Delivery System Also in South America

InspireMD Ltd. is announcing today the availability of a new and improved delivery system for its MGuard™ coronary stent system. The new...